Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

PT-20 did not significantly improve gray hair repigmentation.

Peginterferon alpha-2a effectively treats acute hepatitis C in hemodialysed patients, despite some side effects.

Three specific 4-azasteroid-2-oximes showed strong enzyme inhibition, but less than finasteride.

Equol may help with antiaging and skin health by boosting collagen and blocking certain hormones.

New treatments targeting insulin, blood flow, and inflammation could improve hormone-related hair conditions with fewer side effects.

Chronic GnRHa treatment can help manage endometrial hyperplasia and reduce ovarian androgen excess in PCO patients.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

17β-estradiol can reduce inflammation in the skin.

Stem cell-derived cytokines and growth factors may be a promising alternative for treating hair loss.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

Spironolactone has the most side effects, including serious risks, while eplerenone and finerenone mainly affect the heart, kidneys, and metabolism.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

SUN11602 and ONO-1301 could help in skin healing and creating artificial skin.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

New cytokine-targeted therapies show promise for treating alopecia areata.

Hormonal contraceptives and therapies regulate organ functions and treat various conditions.

SPIOMET therapy may be a promising alternative to oral contraceptives for treating adolescent PCOS.

Modified HDL can better deliver drugs and genes, potentially improving treatments and reducing side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.